European Journal of Heart Failure

Titel Veröffentlichungsdatum Sprache Zitate
The blood urea nitrogen to creatinine ratio in chronic heart failure: ‘When the past is prologue’2024/01/18English
Differing beta‐blocking effects of carvedilol and metoprolol2001/06/01English
The CARE‐HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end‐points2001/08/01English
Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction1999/12/01English
Effects of systematic education on heart failure patients' knowledge after 6 months. A randomised, controlled trial1999/08/01English
Angiotensin in cardiac surgery: efficacy in patients on angiotensin converting enzyme inhibitors2001/10/01English
Relationship between cardiac metaiodobenzylguanidine uptake and hemodynamic, functional and neurohormonal parameters in patients with heart failure2001/12/01English
Evaluation of left ventricular function and mitral regurgitation during left ventricular‐based pacing in patients with heart failure2001/08/01English
Improvement of cardiac output in patients with severe heart failure by use of ACE‐inhibitors combined with the AT1‐antagonist eprosartan2000/06/01English
Update of ELITE‐II, BEST, CHAMP, and IMPRESS clinical trials in heart failure2000/03/01English
Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK‐CD, CHRISTMAS, OPTIME‐CHF2001/08/01English
Expanding the knowledge on transthyretin p.V142I variant‐related cardiomyopathy2024/01/28English
Atrial myopathy and heart failure with preserved ejection fraction: When a label does more harm than good?2024/01/28English
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)2024/01/25English
Advantage of uptitration of foundational heart failure drugs in heart failure with reduced ejection fraction and low blood pressure2024/01/25English
Reply to the letter regarding the article ‘Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines’2024/01/16English
Issue Information2023/06/01English
Acetazolamide as a decongestion strategy in acute decompensated heart failure: Balancing fluid removal and electrolyte disturbances2023/06/27English
Thromboembolic events in peripartum cardiomyopathy: Current dilemmas and future perspectives2023/06/21English
Issue Information2023/05/01English
May 2023 at a glance: focus on pathophysiology, comorbidities and devices2023/05/01English
Optimizing heart rate with ivabradine in heart failure with reduced ejection fraction: Insights from a post‐hoc analysis of the SHIFT trial2023/07/05English
Vericiguat in heart failure with reduced ejection fraction: The right choice above all else? The answer may lie in time. Letter regarding the article ‘Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudy’2023/06/21English
Globalization does not lead to homogenization in randomized controlled trials: Impact on sample size estimation2023/07/04English
Invasive exercise haemodynamics: an oracle in heart failure with preserved ejection fraction diagnosis and prognostication2023/02/01English
De novo aortic regurgitation related to left ventricular assist device therapy: the difficult questions in need of new perspectives2023/01/05English
Issue Information2022/12/01English
December 2022 at a glance: heart failure with preserved ejection fraction, sodium–glucose cotransporter 2 inhibitors and cardiac amyloidosis2022/12/01English
His bundle pacing for correcting atrioventricular dyssynchrony in heart failure: HYPE or HOPE?2023/02/01English
Are post‐influenza vaccine reactions truly ‘adverse’?2023/01/22English